01
Low NADAC$0.065
→
Avg plan cost$0.264
Part D spend $116.2M
4× spread, current vs floor
6 molecules in this class, $116.2M combined CY2024 Part D spend across 6.0M claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.
Every drug in the Polyene Antifungal class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.